Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Analgesic & Pain Relievers
1.2.3 Dermatological Products
1.2.4 Cough, Cold, and Flu Products
1.2.5 Vitamin Supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Market by Application
1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Perspective (2018-2034)
2.2 Over the Counter (OTC) Drugs & Dietary Supplements Growth Trends by Region
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Region (2018-2023)
2.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2024-2034)
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Dynamics
2.3.1 Over the Counter (OTC) Drugs & Dietary Supplements Industry Trends
2.3.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
2.3.3 Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
2.3.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue
3.1.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2018-2023)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Players (2018-2023)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Over the Counter (OTC) Drugs & Dietary Supplements Revenue
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio
3.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2024
3.5 Over the Counter (OTC) Drugs & Dietary Supplements Key Players Head office and Area Served
3.6 Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
3.7 Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Type (2018-2023)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2024-2034)
5 Over the Counter (OTC) Drugs & Dietary Supplements Breakdown Data by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Size by Application (2018-2023)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2034)
6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
6.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2034)
7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
7.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2034)
8.2 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023)
8.4 Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2034)
9.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
9.4 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size (2018-2034)
10.2 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023)
10.4 Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.1.4 Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Novartis International AG
11.2.1 Novartis International AG Company Detail
11.2.2 Novartis International AG Business Overview
11.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.2.4 Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.2.5 Novartis International AG Recent Development
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Detail
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.3.4 Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.3.5 Roche Holding AG Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Detail
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.4.4 Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Sanofi S.A
11.5.1 Sanofi S.A Company Detail
11.5.2 Sanofi S.A Business Overview
11.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.5.4 Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.5.5 Sanofi S.A Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.6.4 Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Detail
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.7.4 Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.7.5 Gilead Sciences Recent Development
11.8 GlaxoSmithKline plc.
11.8.1 GlaxoSmithKline plc. Company Detail
11.8.2 GlaxoSmithKline plc. Business Overview
11.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.8.4 GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.8.5 GlaxoSmithKline plc. Recent Development
11.9 Bayer Healthcare AG
11.9.1 Bayer Healthcare AG Company Detail
11.9.2 Bayer Healthcare AG Business Overview
11.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.9.4 Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.9.5 Bayer Healthcare AG Recent Development
11.10 AstraZeneca plc.
11.10.1 AstraZeneca plc. Company Detail
11.10.2 AstraZeneca plc. Business Overview
11.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.10.4 AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.10.5 AstraZeneca plc. Recent Development
11.11 Alacer Corp.
11.11.1 Alacer Corp. Company Detail
11.11.2 Alacer Corp. Business Overview
11.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.11.4 Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.11.5 Alacer Corp. Recent Development
11.12 Alcon Inc.
11.12.1 Alcon Inc. Company Detail
11.12.2 Alcon Inc. Business Overview
11.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.12.4 Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.12.5 Alcon Inc. Recent Development
11.13 Alfresa Pharma Corporation
11.13.1 Alfresa Pharma Corporation Company Detail
11.13.2 Alfresa Pharma Corporation Business Overview
11.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.13.4 Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.13.5 Alfresa Pharma Corporation Recent Development
11.14 Alkalon A/S
11.14.1 Alkalon A/S Company Detail
11.14.2 Alkalon A/S Business Overview
11.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.14.4 Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.14.5 Alkalon A/S Recent Development
11.15 Alliance Healthcare
11.15.1 Alliance Healthcare Company Detail
11.15.2 Alliance Healthcare Business Overview
11.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.15.4 Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.15.5 Alliance Healthcare Recent Development
11.16 Allergan, Plc.
11.16.1 Allergan, Plc. Company Detail
11.16.2 Allergan, Plc. Business Overview
11.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.16.4 Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.16.5 Allergan, Plc. Recent Development
11.17 Reckitt Benckiser Plc.
11.17.1 Reckitt Benckiser Plc. Company Detail
11.17.2 Reckitt Benckiser Plc. Business Overview
11.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.17.4 Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.17.5 Reckitt Benckiser Plc. Recent Development
11.18 Bausch & Lomb
11.18.1 Bausch & Lomb Company Detail
11.18.2 Bausch & Lomb Business Overview
11.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.18.4 Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.18.5 Bausch & Lomb Recent Development
11.19 AbbVie Inc.
11.19.1 AbbVie Inc. Company Detail
11.19.2 AbbVie Inc. Business Overview
11.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.19.4 AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.19.5 AbbVie Inc. Recent Development
11.20 The Colgate-Palmolive Company
11.20.1 The Colgate-Palmolive Company Company Detail
11.20.2 The Colgate-Palmolive Company Business Overview
11.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Introduction
11.20.4 The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
11.20.5 The Colgate-Palmolive Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Analgesic & Pain Relievers
Table 3. Key Players of Dermatological Products
Table 4. Key Players of Cough, Cold, and Flu Products
Table 5. Key Players of Vitamin Supplements
Table 6. Key Players of Mineral Supplements
Table 7. Key Players of Ophthalmic Products
Table 8. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2018-2023)
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2024-2034)
Table 14. Over the Counter (OTC) Drugs & Dietary Supplements Market Trends
Table 15. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers
Table 16. Over the Counter (OTC) Drugs & Dietary Supplements Market Challenges
Table 17. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players (2018-2023)
Table 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2024)
Table 21. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Over the Counter (OTC) Drugs & Dietary Supplements Product Solution and Service
Table 25. Date of Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2018-2023)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2024-2034)
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2018-2023)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2024-2034)
Table 35. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034) & (US$ Million)
Table 38. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 39. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034) & (US$ Million)
Table 41. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 42. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (2024-2034) & (US$ Million)
Table 44. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034) & (US$ Million)
Table 47. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 48. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Country (2024-2034) & (US$ Million)
Table 50. Pfizer Inc. Company Detail
Table 51. Pfizer Inc. Business Overview
Table 52. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 53. Pfizer Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 54. Pfizer Inc. Recent Development
Table 55. Novartis International AG Company Detail
Table 56. Novartis International AG Business Overview
Table 57. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 58. Novartis International AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 59. Novartis International AG Recent Development
Table 60. Roche Holding AG Company Detail
Table 61. Roche Holding AG Business Overview
Table 62. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 63. Roche Holding AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 64. Roche Holding AG Recent Development
Table 65. Merck & Co., Inc. Company Detail
Table 66. Merck & Co., Inc. Business Overview
Table 67. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 68. Merck & Co., Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 69. Merck & Co., Inc. Recent Development
Table 70. Sanofi S.A Company Detail
Table 71. Sanofi S.A Business Overview
Table 72. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 73. Sanofi S.A Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 74. Sanofi S.A Recent Development
Table 75. Johnson & Johnson Company Detail
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 78. Johnson & Johnson Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 79. Johnson & Johnson Recent Development
Table 80. Gilead Sciences Company Detail
Table 81. Gilead Sciences Business Overview
Table 82. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 83. Gilead Sciences Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 84. Gilead Sciences Recent Development
Table 85. GlaxoSmithKline plc. Company Detail
Table 86. GlaxoSmithKline plc. Business Overview
Table 87. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 88. GlaxoSmithKline plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 89. GlaxoSmithKline plc. Recent Development
Table 90. Bayer Healthcare AG Company Detail
Table 91. Bayer Healthcare AG Business Overview
Table 92. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 93. Bayer Healthcare AG Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 94. Bayer Healthcare AG Recent Development
Table 95. AstraZeneca plc. Company Detail
Table 96. AstraZeneca plc. Business Overview
Table 97. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 98. AstraZeneca plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 99. AstraZeneca plc. Recent Development
Table 100. Alacer Corp. Company Detail
Table 101. Alacer Corp. Business Overview
Table 102. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 103. Alacer Corp. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 104. Alacer Corp. Recent Development
Table 105. Alcon Inc. Company Detail
Table 106. Alcon Inc. Business Overview
Table 107. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 108. Alcon Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 109. Alcon Inc. Recent Development
Table 110. Alfresa Pharma Corporation Company Detail
Table 111. Alfresa Pharma Corporation Business Overview
Table 112. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 113. Alfresa Pharma Corporation Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 114. Alfresa Pharma Corporation Recent Development
Table 115. Alkalon A/S Company Detail
Table 116. Alkalon A/S Business Overview
Table 117. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 118. Alkalon A/S Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 119. Alkalon A/S Recent Development
Table 120. Alliance Healthcare Company Detail
Table 121. Alliance Healthcare Business Overview
Table 122. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 123. Alliance Healthcare Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 124. Alliance Healthcare Recent Development
Table 125. Allergan, Plc. Company Detail
Table 126. Allergan, Plc. Business Overview
Table 127. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 128. Allergan, Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 129. Allergan, Plc. Recent Development
Table 130. Reckitt Benckiser Plc. Company Detail
Table 131. Reckitt Benckiser Plc. Business Overview
Table 132. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 133. Reckitt Benckiser Plc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 134. Reckitt Benckiser Plc. Recent Development
Table 135. Bausch & Lomb Company Detail
Table 136. Bausch & Lomb Business Overview
Table 137. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 138. Bausch & Lomb Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 139. Bausch & Lomb Recent Development
Table 140. AbbVie Inc. Company Detail
Table 141. AbbVie Inc. Business Overview
Table 142. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 143. AbbVie Inc. Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 144. AbbVie Inc. Recent Development
Table 145. The Colgate-Palmolive Company Company Detail
Table 146. The Colgate-Palmolive Company Business Overview
Table 147. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 148. The Colgate-Palmolive Company Revenue in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023) & (US$ Million)
Table 149. The Colgate-Palmolive Company Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Type: 2024 VS 2034
Figure 3. Analgesic & Pain Relievers Features
Figure 4. Dermatological Products Features
Figure 5. Cough, Cold, and Flu Products Features
Figure 6. Vitamin Supplements Features
Figure 7. Mineral Supplements Features
Figure 8. Ophthalmic Products Features
Figure 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application: 2024 VS 2034
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Online Pharmacy Case Studies
Figure 14. Others Case Studies
Figure 15. Over the Counter (OTC) Drugs & Dietary Supplements Report Years Considered
Figure 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region: 2024 VS 2034
Figure 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Players in 2024
Figure 20. Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2024
Figure 22. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. North America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2034)
Figure 24. United States Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2034)
Figure 28. Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Asia-Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Region (2018-2034)
Figure 36. China Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. India Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Australia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2034)
Figure 44. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Country (2018-2034)
Figure 48. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Pfizer Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 51. Novartis International AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 52. Roche Holding AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 53. Merck & Co., Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 54. Sanofi S.A Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 55. Johnson & Johnson Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 56. Gilead Sciences Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 57. GlaxoSmithKline plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 58. Bayer Healthcare AG Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 59. AstraZeneca plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 60. Alacer Corp. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 61. Alcon Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 62. Alfresa Pharma Corporation Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 63. Alkalon A/S Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 64. Alliance Healthcare Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 65. Allergan, Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 66. Reckitt Benckiser Plc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 67. Bausch & Lomb Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 68. AbbVie Inc. Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 69. The Colgate-Palmolive Company Revenue Growth Rate in Over the Counter (OTC) Drugs & Dietary Supplements Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed